Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
(Thomson Reuters ONE) -
World-leading life science data from Thomson Reuters Cortellis now available to
third-party developers
Philadelphia, PA, London, UK, April 23, 2012 - The Intellectual Property &
Science business of Thomson Reuters, the world's leading source of intelligent
information for businesses and professionals, today announced the launch of
Partner Ecosystem , a new initiative that provides access to Thomson Reuters
life sciences information through application-specific solutions developed with
third-party partners.
Through Partner Ecosystem, third-party developers take advantage of the Thomson
Reuters Cortellis open architecture to access the company's content and
technology, creating custom solutions that meet the needs of their customers.
These solutions include Thomson Reuters market-leading ontologies, biological
target information and additional critical information supporting
pharmaceutical business development and competitive intelligence projects. The
flexible approach to information delivery enables companies to integrate Thomson
Reuters trusted drug pipeline data seamlessly into the daily workflow,
delivering on-point information so users can quickly make informed decisions.
In addition, partners gain access to the Cortellis Developer Center, a forum
where client and third-party developers collaborate to share ideas, best
practices, and discuss new applications, as well as obtain technical support
from Thomson Reuters technology and content experts.
"We understand the important role our partners play in working with us to
support the success of our mutual customers. Partner Ecosystem is a step toward
providing the infrastructure and collaboration environment necessary to develop
solutions that support the drug R&D process," said Jon Brett-Harris, executive
vice president of Life Sciences at Thomson Reuters." Partner Ecosystem,
alongside our portfolio of other advanced solutions, provides the life sciences
industry with the necessary tools and information to help address the challenges
our customers face."
The Partner Ecosystem web site for developers can be found at
http://cortellis.thomsonreuters.com/partners/. To become a partner or learn
more, please send an email to Life.Sciences.Partners(at)thomsonreuters.com, or
connect with Thomson Reuters at the Bio-IT World Conference & Expo, April
24-26, in booth 236.
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for
businesses and professionals. We combine industry expertise with innovative
technology to deliver critical information to leading decision makers in the
financial and risk, legal, tax and accounting, intellectual property and science
and media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs approximately 60,000 people and operates in over 100
countries. For more information, go to www.thomsonreuters.com.
CONTACT
Laura Gaze Alyssa Velekei
Thomson Reuters, Intellectual Property & Thomson Reuters
Science alyssa.velekei(at)thomsonreuters.com
laura.gaze(at)thomsonreuters.com +1 215 823 1894
+1 203 868 3340
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Thomson Reuters Corporation via Thomson Reuters ONE
[HUG#1605034]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.04.2012 - 09:38 Uhr
Sprache: Deutsch
News-ID 1105916
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 99 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
"
steht unter der journalistisch-redaktionellen Verantwortung von
Thomson Reuters Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
